Debra Boyd‐Kimball

3.2k citations

25 papers · 2.6k indexed · 1 hit paper · h-index 22

Physiology top 1%
Molecular Biology top 5%
Pharmacology top 2%
Neurology top 2%
Cellular and Molecular Neuroscience top 5%

Co-authors: D. Allan Butterfield Rukhsana Sultana Jon B. Klein H. Fai Poon William M. Pierce Alessandra Castegna Michael L. Merchant William R. Markesbery
Topics: Alzheimer's disease research and treatments (18 papers)Biochemical effects in animals (6 papers)Cholinesterase and Neurodegenerative Diseases (5 papers)
Cited by: Biological Psychiatry Physiology Neurology
Journals: Brain Research Neuroscience Journal of Neurochemistry
Partner nations: United States Italy

In The Last Decade

Debra Boyd‐Kimball

25 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

2018 313 citations D. Allan Butterfield, Debra Boyd‐Kimball Journal of Alzheimer s Disease profile →

Peers

Countries citing papers authored by Debra Boyd‐Kimball

Since Specialization

Citations

This map shows the geographic impact of Debra Boyd‐Kimball's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debra Boyd‐Kimball with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debra Boyd‐Kimball more than expected).

Fields of papers citing papers by Debra Boyd‐Kimball

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debra Boyd‐Kimball. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debra Boyd‐Kimball. The network helps show where Debra Boyd‐Kimball may publish in the future.

Co-authorship network of co-authors of Debra Boyd‐Kimball

This figure shows the co-authorship network connecting the top 25 collaborators of Debra Boyd‐Kimball. A scholar is included among the top collaborators of Debra Boyd‐Kimball based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debra Boyd‐Kimball. Debra Boyd‐Kimball is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Cellular Stress Response (Hormesis) in Response to Bioactive Nutraceuticals with Relevance to Alzheimer Disease 2023 ·Antioxidants and Redox Signaling ·D. Allan Butterfield,Debra Boyd‐Kimball,Tanea T. Reed	15
2	Redox proteomics and amyloid β‐peptide: insights into Alzheimer disease 2018 ·Journal of Neurochemistry ·D. Allan Butterfield,Debra Boyd‐Kimball	88
3	Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Diseasebreakdown → 2018 ·Journal of Alzheimer s Disease ·D. Allan Butterfield,Debra Boyd‐Kimball	313
4	Adaptive Instructional Aids for Teaching a Blind Student in a Nonmajors College Chemistry Course 2012 ·Journal of Chemical Education ·Debra Boyd‐Kimball	33
5	Oxidative modification and down-regulation of Pin1 in Alzheimer's disease hippocampus: A redox proteomics analysis 2005 ·Neurobiology of Aging ·Rukhsana Sultana,Debra Boyd‐Kimball,H. Fai Poon,(unknown),William M. Pierce,Jon B. Klein,William R. Markesbery,Xiao Zhen Zhou,Kun Ping Lu,D. Allan Butterfield	204
6	Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1–42) into rat brain: Implications for Alzheimer’s disease 2005 ·Neuroscience ·Debra Boyd‐Kimball,Rukhsana Sultana,H. Fai Poon,Bert C. Lynn,Fiorella Casamenti,Giancarlo Pepeu,Jon B. Klein,D. Allan Butterfield	129
7	γ‐Glutamylcysteine ethyl ester protection of proteins from Aβ(1–42)‐mediated oxidative stress in neuronal cell culture: A proteomics approach 2005 ·Journal of Neuroscience Research ·Debra Boyd‐Kimball,Rukhsana Sultana,H. Fai Poon,Hafiz Mohmmad‐Abdul,Bert C. Lynn,Jon B. Klein,D. Allan Butterfield	33
8	γ‐glutamylcysteine ethyl ester‐induced up‐regulation of glutathione protects neurons against Aβ(1–42)‐mediated oxidative stress and neurotoxicity: Implications for Alzheimer's disease 2005 ·Journal of Neuroscience Research ·Debra Boyd‐Kimball,Rukhsana Sultana,Hafiz Mohmmad Abdul,D. Allan Butterfield	53
9	Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1–42): Implications for Alzheimer's disease 2005 ·Neurobiology of Aging ·Debra Boyd‐Kimball,H. Fai Poon,Bert C. Lynn,Jian Cai,William M. Pierce,Jon B. Klein,(unknown),Christopher D. Link,D. Allan Butterfield	78
10	Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD 2005 ·Neurobiology of Aging ·Rukhsana Sultana,Debra Boyd‐Kimball,H. Fai Poon,Jian Cai,William M. Pierce,Jon B. Klein,Michael L. Merchant,William R. Markesbery,D. Allan Butterfield	287
11	Proteomic identification of proteins oxidized by Aβ(1–42) in synaptosomes: Implications for Alzheimer's disease 2005 ·Brain Research ·Debra Boyd‐Kimball,Alessandra Castegna,Rukhsana Sultana,H. Fai Poon,Robin T. Petroze,Bert C. Lynn,Jon B. Klein,D. Allan Butterfield	112
12	Nitric oxide and cellular stress response in brain aging and neurodegenerative disorders: the role of vitagenes. 2005 ·PubMed ·Vittorio Calabrese,Debra Boyd‐Kimball,Giovanni Scapagnini,D. Allan Butterfield	143
13	Neurotoxicity and oxidative stress in D1M-substituted Alzheimer's Aβ(1-42): relevance to N-terminal methionine chemistry in small model peptides 2004 ·Peptides ·Debra Boyd‐Kimball,Rukhsana Sultana,Hafiz Mohmmad‐Abdul,D. Allan Butterfield	14
14	Proteomics analysis of human astrocytes expressing the HIV protein Tat 2004 ·Molecular Brain Research ·Chava B. Pocernich,Debra Boyd‐Kimball,H. Fai Poon,Visith Thongboonkerd,Bert C. Lynn,Jon B. Klein,(unknown),Avindra Nath,D. Allan Butterfield	38
15	Proteomic analysis of oxidatively modified proteins induced by the mitochondrial toxin 3-nitropropionic acid in human astrocytes expressing the HIV protein tat 2004 ·Molecular Brain Research ·Chava B. Pocernich,H. Fai Poon,Debra Boyd‐Kimball,Bert C. Lynn,Avindra Nath,Jon B. Klein,D. Allan Butterfield	23
16	The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1–42)-induced oxidative stress and neurotoxicity 2004 ·Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics ·D. Allan Butterfield,Debra Boyd‐Kimball	219
17	Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration 2004 ·International review of neurobiology ·D. Allan Butterfield,Debra Boyd‐Kimball	21
18	Role of Phenylalanine 20 in Alzheimer's Amyloid β-Peptide (1-42)-Induced Oxidative Stress and Neurotoxicity 2004 ·Chemical Research in Toxicology ·Debra Boyd‐Kimball,Hafiz Mohmmad Abdul,Tanea T. Reed,Rukhsana Sultana,D. Allan Butterfield	44
19	Amyloid β‐Peptide(1‐42) Contributes to the Oxidative Stress and Neurodegeneration Found in Alzheimer Disease Brain 2004 ·Brain Pathology ·D. Allan Butterfield,Debra Boyd‐Kimball	215
20	Proteomics in Alzheimer's disease: insights into potential mechanisms of neurodegeneration 2003 ·Journal of Neurochemistry ·D. Allan Butterfield,Debra Boyd‐Kimball,Alessandra Castegna	152

About Debra Boyd‐Kimball

Debra Boyd‐Kimball is a scholar working on Physiology, Virology and Biochemistry, having authored 25 papers that have together received 2.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (18 papers), Biochemical effects in animals (6 papers) and Cholinesterase and Neurodegenerative Diseases (5 papers). The work is most often cited by research in Biological Psychiatry (195 citations), Physiology (1.5k citations) and Neurology (302 citations). Debra Boyd‐Kimball has collaborated with scholars based in United States and Italy. Frequent co-authors include D. Allan Butterfield, D. Allan Butterfield, Rukhsana Sultana, Jon B. Klein, H. Fai Poon, William M. Pierce, Alessandra Castegna, Michael L. Merchant, William R. Markesbery and Bert C. Lynn. Their work appears in journals such as Brain Research, Neuroscience and Journal of Neurochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact